Menu

Pharma

Government Mulls Relaxing FDI Rules for E-Commerce Exports — Who Wins, and by how much?

Government Mulls Relaxing FDI Rules for E-Commerce Exports — Who Wins, and by how much?

Government Mulls Relaxing FDI Rules for E-Commerce Exports — Who Wins, and by how much?

On 25 September 2025 Reuters reported that the Directorate General of Foreign Trade (DGFT) circulated a confidential draft that would permit foreign e-commerce platforms (e.g., Amazon) to directly purchase Indian goods for export via dedicated export entities, subject to compliance and penalties. The draft is explicitly export-only and requires cabinet approval; timing for finalisation remains unclear. This is the immediate policy event investors should watch.

Why the change matters
India’s goods exports (FY25) were roughly ₹3.12 lakh crore (~US$36.6bn) for textiles and apparel segments — textiles account for a substantial share of export volumes and a direct channel to global marketplaces can materially shorten time-to-market. The policy’s objective (per reporting) is to lift export participation of small sellers (currently <10%) and to support platform goals (e.g., Amazon cited an ambition to lift exports from $13bn since 2015 toward much higher targets). If implemented, this could accelerate export volumes and unit economics for many MSME sellers.

Textiles & Apparel
Investors should watch export revenue share, EBITDA margin, inventory turns and leverage. India textile exporters posted FY24–FY25 revenue growth and modest margin improvement: sector EBITDA margins among organised apparel players are in the ~9–13% band (industry trackers report mid-single-digit to low-teens operating margins in FY25), with export-heavy firms often delivering EBITDA margin ≈11%. Healthy listed textile names often target Net Debt / EBITDA <2.0x; firms above 2.5x are leverage-sensitive if working capital expands. Expect quicker order conversion and higher inventory days if platforms hold exported inventory — test models with inventory days +10–30% scenarios.

Pharmaceuticals & CDMOs
Leading domestic pharma players show wide margin dispersion. A concrete example: Mankind Pharma’s Q1 FY26 presentation reported an EBITDA margin of 23.8% (Q1 FY26) and improving ROCE metrics — a template for consumer/OTC players riding platform exports. For export-oriented contract manufacturers, expect EBITDA margins typically ~15–25%, with Net Debt/EBITDA often <1.5x for defensive mid-caps but vulnerable MSMEs may run >2.0x leverage. Regulatory compliance and GMP certification remain gating constraints (and can affect margin conversion).

Electronics & Components (EMS / small appliances)
Industry reports (PwC, SAS Partners) show India’s electronics objective and rising exports; typical listed EMS/OEM incumbents trade with EBITDA margins ~6–12% depending on product mix. For capital-light electronics suppliers (components / accessories), EBITDA margin nearer 8–10% and Net Debt / EBITDA 0.5–1.5x are common. Unit economics for cross-border e-commerce rely on logistics cost per order and return rates; model take-rate / fulfilment cost per order for margin break-even (>10% of AOV is risky).

Agri-processing & Food (packaged foods)
Agri-processors tend to have lower operating margins; listed players show EBITDA margins ~6–12% (higher for branded, lower for commodity processors). Working capital days (inventory + receivables) are critical: watch OCF / Sales and current ratio. Firms with Operating Cash Flow / Net Income >1.0 and Net Debt/EBITDA <2.0x will scale export pilots more comfortably.

Logistics & Fulfilment partners
Logistics partners that handle cross-border fulfilment often deliver EBITDA margins ~7–10%; their incremental scale benefits (higher utilisation) can lift margins 150–300 bps. Track asset turns, EV/EBITDA and free cash flow conversion.

What investors should do now
1. Map exposure: identify portfolio names with >20% seller exposure to platform exports or supply-chain links (logistics, packaging).
2. Wait for formal policy text: do not assume the draft will pass unchanged; focus on cabinet approval and DGFT notification dates.
3. Screen for unit economics: prefer companies where adjusted EBIT margin is positive or improving and Net Debt/EBITDA <2x.
4. Use event-driven sizing: initiate small positions on confirmed pilots or sanction letters; increase on clear tariff/compliance frameworks.
5. Hedge distribution risk: consider short-dated hedges or reduce size where seller concentration or low cash conversion is evident.

Conclusion
The DGFT draft of 25 September 2025 opens a possible new export channel that could materially improve market access for Indian SMEs. Textile, pharma, electronics and agri-processing could be principal gainers – but investors must demand hard, prospectus-level unit economics, low leverage and explicit policy clarity before re-rating names. The policy’s final shape and cabinet timetable will determine who wins and who gets squeezed.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The image added is for representation purposes only

Ashok Leyland–CALB Tie-Up: A Game Changer for EV Investors

Dabur Subsidiaries Face Cancer Lawsuits in US and Canada

Are homemade remedies really beneficial?

Are homemade remedies really beneficial? Fruits and vegetables as well as herbs and spices are used to cure diseases through homemade remedies. Homemade remedies were used in the earliest form...